Finance

Results: 29425-29436 of 39891

PR Newswire associated0

New Momentum in Pharma Automation: ArisGlobal's 2024 Industry Survey Report Highlights Surge in AI-Powered Safety & Regulatory Processes

PR Newswire associated0

A Connected and Sustainable Energy World - 17th Singapore International Energy Week

Greenland Resources Submits Updated Social Impact Assessment

Biotechnology scientist and entrepreneur and Kindeva Drug Delivery’s Head of the Scientific Advisory Board, John Patton (second from the left), was named the winner of the Charles G. Thiel Award for outstanding research and discovery in respiratory drug delivery at this year’s Respiratory Drug Delivery (RDD) Conference. Also pictured (from left to right): Michael Hindle, Ph.D., Professor, School of Pharmacy at Virginia Commonwealth University, Stephen Stein, Scientific Director of Inhalation Product Development at Kindeva, and Milton Boyer, CEO at Kindeva. (Photo: Business Wire)

John Patton, Head of Kindeva Drug Delivery’s Scientific Advisory Board, Named Winner of RDD Conference’s Charles G. Thiel Award

IGI Establishes a Presence in Lloyd’s, Begins Trading May 9, 2024

PR Newswire associated0

BLOOMBERG MEDIA AND EMERITUS PARTNER TO LAUNCH "BLOOMBERG LEARNING"

PR Newswire associated0

20 FINALISTS ANNOUNCED IN XPRIZE CARBON REMOVAL RACING TO REVERSE CLIMATE CHANGE

Atlantica Reports First Quarter 2024 Financial Results

Kojamo plc Interim Report 1 January-31 March 2024

Invitation to news conference: Kamux Corporation publishes its Interim Report for January-March on May 17, 2024

Eight Sleep introduces Pod 4 Ultra, the most effective sleep technology now detects and stops snoring, has twice the cooling power and offers adjustable sleep positions. (Photo: Business Wire)

Eight Sleep Introduces Pod 4 Ultra: The Most Effective Sleep Technology Now Detects and Stops Snoring, Has Twice The Cooling Power, and Offers Adjustable Sleep Positions

OKYO Pharma Announces Participation in May 2024 Investor Conferences